Register
Forgot your password?

Survival after myocardial revascularization in patients with stable coronary disease – 7-year intermediate resultsISCHEMIA trial

Authors: Golukhova E.Z.

Company: Bakoulev National Medical Research Center for Cardiovascular Surgery, Moscow, Russian Federation

For correspondence:  Sign in or register.

Type:  Editorial article


DOI: https://doi.org/10.24022/1997-3187-2023-17-1-7-10

For citation: Golukhova E.Z. Survival after myocardial revascularization in patients with stable coronary disease – 7-year intermediate results of ISCHEMIA trial. Creative Cardiology. 2023; 17 (1): 7–10 (in Russ.). DOI: 10.24022/1997-3187-2023-17-1-7-10

Received / Accepted:  25.03.2023 / 29.03.2023

Keywords: ISCHEMIA trial chronic coronary syndrome coronary artery disease percutaneous coronary intervention medical treatment endovascular intervention

Download
Full text:  

 

Abstract

Author analyzes the results of The ISCHEMIA trial (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) compared an initial invasive versus an initial conservative strategy for patients with chronic coronary artery disease and moderate or severe ischemia. There were no major differences in most outcomes during a median of 3.2 years and extended follow-up period up to 7 years despite lower 7-years rate cardiovascular mortality with initial invasive strategy group. Quality of life also improved with an initial invasive strategy.

References

  1. Knuuti J., Wijns W., Saraste A., Capodanno D., Barbato E., Funck-Brentano C. et al. ESC Scientific Document Group, 2019 ESCGuidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chroniccoronary syndromes of the European Society of Cardiology (ESC). Eur. Heart J. 2020; 41 (3): 407–77. DOI: 10.1093/ eurheartj/ehz425
  2. Maron D., Hochman J.S., Reynolds H., Bangalore S., O’Brien S.M., Boden W.E. et al. Initial invasive or conservative strategy forstable coronary disease. N. Engl. J. Med. 2020; 382 (15): 1395–407. DOI: 10.1056/NEJMoa1915922
  3. Spertus J.A., Jones Ph.G., Maron D.J.,O’Brien S.M., Reynolds H.R., Rosenberg Y. Health-status outcomes with invasive or conservative care in coronary disease. N. Engl. J.Med 2020; 382: 1408–19. DOI: 10.1056/NEJMoa1916370
  4. Hochman J., Anthopolos R., Reynolds H., Bangalore S., Xu Y., O’Brien S.M. etal. Survival after invasive or conservative management of stable coronary disease. Circulation. 2023; 147 (1): 8–19. DOI:10.1161/CIRCULATIONAHA.122.062714

About Authors

Elena Z. Golukhova, Dr. Med. Sci., Professor, Academician of Russian Academy of Sciences, Director; ORCID

Chief Editor

Elena Z. Golukhova, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, Director of Bakoulev National Medical Research Center for Cardiovascular Surgery


Sort by